Zdrowie i gospodarka · 07/03/2018

FDA Classifies Extracorporeal Shock Wave Device for Chronic Wound Treatment into Class II with Special Controls

The FDA has classified the extracorporeal shock wave device for treating chronic wounds into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.